Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06107231 · ClinicalTrials.gov registry record · NA
WHNRC (Western Human Nutrition Research Center) Honey Study
A NA study of Cognitive Change and Postprandial Glycemia, sponsored by USDA, Western Human Nutrition Research Center.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06107231: Active NA study of Cognitive Change and Postprandial Glycemia, sponsored by USDA, Western Human Nutrition Research Center.
NCT06107231 is a NA study of Cognitive Change and Postprandial Glycemia that is active but no longer recruiting, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 80 participants, below the 178-participant average among 44 other Cognitive Change trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06107231, a NA study of Cognitive Change and Postprandial Glycemia, is active but no longer recruiting, sponsored by USDA, Western Human Nutrition Research Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to compare two snacks, one with honey and nuts and the other with sugar and nuts, on glucose levels before and after eating these snacks. The investigators hypothesize that honey and nuts will have an additive effect on the reduction of postprandial glucose response. The investigators further hypothesize that consumption of honey paired with nuts will retain the benefit of sugar consumption in satiety and reduction of metabolic stress.
Primary Outcome
Interstitial glucose response measured by a continuous glucose monitor
Conditions Studied
Interventions
- OTHER Sucrose
- OTHER Honey
- OTHER Honey plus almonds
- OTHER Sucrose plus almonds
Study Locations (1)
California
- USDA, ARS, Western Human Nutrition Research Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-01-16 |
| Est. Completion | 2026-10-30 |
| Phase | NA |
What the registry record for NCT06107231 still lists
NCT06107231 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 178-participant average among 44 other Cognitive Change trials with a reported enrollment target (55% lower).
The record links to 4 conditions, with Cognitive Change appearing as the primary indexed condition, and to 4 interventions - of which Sucrose is the first listed.
NCT06107231 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06107231 about?
NCT06107231 is a clinical study titled "WHNRC (Western Human Nutrition Research Center) Honey Study". The purpose of this research is to compare two snacks, one with honey and nuts and the other with sugar and nuts, on glucose levels before and after eating these snacks. The investigators hypothesize that honey and nuts will have an additive effect on the reduction of postprandial glucose response....
What is the current status of trial NCT06107231?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-01-16. Estimated completion is 2026-10-30.
What conditions does trial NCT06107231 study?
This clinical trial studies the following conditions: Cognitive Change, Postprandial Glycemia, Metabolic Stress, Satisfaction, Personal.
What interventions are being tested in trial NCT06107231?
The interventions under investigation include: Sucrose (OTHER), Honey (OTHER), Honey plus almonds (OTHER), Sucrose plus almonds (OTHER).
Who is sponsoring clinical trial NCT06107231?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06107231 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Change
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06107231's enrollment target sits among peer trials
80 19th of 44 higher than 23 of 44 other Cognitive Change trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognitive Change trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Moderators and Mediators of Perceptual Learning
RECRUITING · NA
-
Amplitude Titration to Improve ECT Clinical Outcomes
RECRUITING · NA
-
The Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults
RECRUITING · NA
-
Remote Evaluation of MIND Diet
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI